Skip to main content
Moving forward with treatment.

Treatment procedures for ITVISMA

.

icon of a triangle with an exclamation point inside

Infections

Clinical signs or symptoms of infection should not be evident at the time of ITVISMA administration.1

icon of carton and vial

Single-dose vial

Each carton of ITVISMA contains a single-dose vial with an extractable volume of not less than 3 mL, containing 1.2 × 1014 vg.1

icon of a spinal cord with purple arrows pointing into it

Intrathecal administration

Prior to administration, remove 3 mL of CSF using a lumbar puncture needle. Then administer ITVISMA as an intrathecal bolus injection over approximately 1 to 2 minutes.1

Learn the steps involved to get your patients treated with ITVISMA

Review key steps before administration and learn about patient management after treatment. Click the sections below for more information. 

CSF, cerebrospinal fluid; SMA, spinal muscular atrophy; vg, vector genome.
Reference: 1. ITVISMA. Prescribing information. Novartis Gene Therapies, Inc.